Diabetes Mellitus tipo 2 y puntuaciones de riesgo

Diana María Arman Pereda, Leonel Gallardo Madrazo, Adrian Augusto Naranjo Dominguez, Marbelia Diaz Calzada, Gabino Ernesto Arman Alessandrini

Texto completo:

PDF

Resumen

La diabetes mellitus está emergiendo más rápidamente que cualquier otra enfermedad. Se ha demostrado que la prevención de la Diabetes tipo 2 es posible y requiere de acción inmediata basada en cambios del estilo de vida sostenidos en la dieta y en la actividad física, además de la identificación a nivel poblacional de los grupos con mayor riesgo de padecer la enfermedad. La presente investigación se realizó con el objetivo de caracterizar la diabetes mellitus así como las diferentes puntuaciones de riesgo existentes para la identificación de individuos con probabilidad de desarrollar diabetes mellitus tipo 2 sin alteraciones previas de la glucemia, para lo cual se consultaron un total de 46 referencias bibliográficas.

ABSTRACT

Diabetes mellitus is emerging more quickly than any other illness. It is not still possible to prevent the diabetes type 1 and this goal remains as an objective of the future. Has been demonstrated that the prevention of the Diabetes type 2 is possible and it requires of immediate action based on changes of the lifestyle sustained in the diet and in the physical activity, besides the identification at populational level of the groups with more risk of suffering the illness. The present investigation was carried out with the objective of characterizing the diabetes mellitus as well as the existent different punctuations of risk for the identification of individuals with probability of developing diabetes mellitus type 2 without previous alterations of the glycaemia, for that which a total of 46 bibliographical references were consulted.

Palabras clave

diabetes mellitus; prevención; escalas de riesgo;diabetes mellitus; prevention; scales of risk

Referencias

de la Paz KL, Proenza L, Gallardo Y, Fernández S, Mompié A. Factores de riesgo en adultos mayores con diabetes mellitus. MEDISAN; 2012; 16(4). Disponible en: http://scielo.sld.cu/scielo.php?script=sci_arttext&pid=S1029-301920120

Gutiérrez A, Laourou EL, Álvarez JA, Blas B, Gutiérrez AA. Diabesidad y su riesgo cardiovascular global. 16 de Abril. 2014; 53(255): 5-16

American Diabetes Association. Diagnosis and classification of DM. Diabetes Care. 2014; 37(suppl 1):62–67. Disponible en: http://care.diabetesjournals.org/content/37/Supplement_1/S5.full

Shaw JE, Sicree RA, Zimmet PZ. Global estimates of the prevalence of diabetes for 2010 and 2030. Diabetes Research and Clinical Practice. 2010; 87(1): 4-14

Tuomilehto J, Lindström J, Hellminch M, Lehmacher W, Westermeier T, Evers T. Development and validation of a risk-score model for subjects with impaired glucose tolerance for the assessment of the risk of type 2 diabetes mellitus-The STOP-NIDDM risk-score. Diabetes Research and Clinical Practice. 2010; 87(2):267-74

Ministerio de Salud Pública, República de Cuba. Dirección Nacional de Registros Médicos y Estadísticas de Salud. Anuario Estadístico de Salud 2013

Salama BA, Sánchez G. Factores de riesgo y complicaciones crónicas en el diagnóstico reciente de la diabetes tipo 2. Rev Cub de Endocrinología. 2001; 12(2): 76-81

Markku L, Johanna K. Insulin resistance and hyperglycemia in cardiovascular disease development. Nature Reviews Endocrinology. 2014; 10(5): 293-302

López F, Simha V, Thomas RJ, Allison TG, Basu A, Fernandes R, et al. A Summary and Critical Assessment of the 2013 ACC/AHA Guideline on the Treatment of Blood Cholesterol to Reduce Atherosclerotic Cardiovascular Disease Risk in Adults: Filling the Gaps. Clinic Proceedings. 2014; 89(9): 1257-780

Perera E, Ramos M, Padilla CM, Hernández JR, Ruiz M, Hernández H. Comportamiento clínico-epidemiológico de la retinopatía diabética en el municipio Marianao de agosto a noviembre de 2007. Rev Cubana Oftalmol. 2011; 24(2). Disponible en: http://scielo.sld.cu/scielo.php?script=sci_arttext&pid=S0864-217620110

Cruz RE, Fuentes O, Gutiérrez O, Garay R, Águila O. Nefropatía diabética en paciente diabéticos tipo 2. Rev Cub Med. 2011; 50(1). Disponible en: http://scielo.sld.cu/scielo.php?script=sci_arttext&pid=S0034-752320110

Valdés E, Espinosa Y. Factores de riesgo asociados con la aparición de enfermedad arterial periférica en personas con diabetes mellitus tipo 2. Rev Cubana Med. 2013; 52(1). Disponible en: http://scielo.sld.cu/scielo.php?script=sci_arttext&pid=S0034-752320130

Towfighi A, Markovic D, Obbiagele B. Utility of Framingham Coronary Heart Disease Risk Score for Predicting Cardiac Risk after Stroke. Stroke. 2012; 43: 2942-47

Singh JP, Larson MG, O’Donnell CJ, Wilson PF, Tsuji H, Lloyd DM, et al. Assciation of hyperglycemia with reduced Herat rate variability (The Framingham Heart Study). Am J Cardiol. 2000; 86:309-12

Sebayan B, Gussekloo J, Ruijter W, Westendorp R, de Craen JM. Framingham Stroke Risk Score and Cognitive Impairment for Predicting First-Time Stroke in the Oldest Old. Stroke. 2013; 44: 1866-71

González RM, Perich P, Arranz C. Trastornos metabólicos asociados con la evolución hacia la DM tipo 2 en una población en riesgo. Rev Cub Endocrinología [Internet]. 2010 [citada 5 Sep 2015]; 21(2). Disponible en: http://scielo.sld.cu/scielo.php?script=sci_issuetoc&pid=1561295320100002&lng=es&nrm=iso

Espinosa A, Rodríguez AL, Sánchez M. Diabetes mellitus tipo 2: enfoque de su riesgo cardiovascular. 16 de Abril. 2014; 53(255): 101-15

Sassoli VP, Carvalho CA, Moraes M, Nessler R, Charles K. Diabetic Peripheral Neuropathies: A Morphometric Overview. Int J Morphol. 2010; 28(1):51-64. Disponible en: http://www.scielo.cl/scielo.php?script=sci_arttext&pid=S0717-9502201

Olmos PR, Niklitschek S, Olmos RI, Faúndez JI, Quezada TA, Bozinovic MA, et al. Bases fisiopatológicas para una clasificación de la neuropatía diabética. Rev Med Chile. 2012; 140(12): 1593-605. Disponible en: http://www.scielo.cl/scielo.php?script=sci_arttext&pid=S0034-9887201

Farreras R. Medicina interna. Elsevier. 2012. España. Versión digital. [Citado 2014 diciembre 20]. Disponible en: https://www.clinicalkey.es/

Inzucchi SE, Sherwin RS. Diabetes mellitus tipo 2. Goldman L, Schafer A. Goldman´s Cesil Medicin. Elsevier. 2013. España. Versión digital. [Citado 2014 diciembre 20]. Disponible en: https://www.clinicalkey.es/

Mario P, Wanda A, Giovanni F, Cuocolo A. Cardiovascular risk stratification in diabetic patients. Clinical and Translational Imaging. 2013; 1(5): 325-39

Bacha F, Lee SJ, Gungor N, Arslanian SA. From Pre-Diabetes to Type 2 Diabetes in Obese Youth Pathophysiological characteristics along the spectrum of glucose dysregulation. Diabetes Care. 2010; 33(10): 2225-31

Mahon J. A single screening for type 2 diabetes in high-risk adults did not reduce mortality over 10 years. Ann Intern Med. 2013; 158(2)

Glümer C, Carstensen B, Sandbaek A, Lauritzen T, Jørgensen T, Borch-Johnsen K. A Danish diabetes risk score for targeted screening: the Inter99 study. Diabetes Care. 2004; 27:727-33

Lee YH, Bang H, Kim HC, Kim HM, Park SW, Kim DJ. A Simple Screening Score for Diabetes for the Korean Population. Development, validation, and comparison with other scores. Diabetes Care. 201; 35(8): 1723-30

Sharma KM, Rajani HR, Nguyen H, Shetty S, Datta M, Venkat KM. Indian Diabetes Risk Score Helps to Distinguish Type 2 from Non-Type 2 Diabetes Mellitus (GDRC-3). J Diabetes Sci Technol. 2011; 5(2):419-25

Gao WG, Dong YH, Pang ZC, Nan HR, Wang SJ, Ren J. A simple Chinese risk score for undiagnosed diabetes. Diabetic Medicine. 2010; 27(3):274-81

Xie J, Hu D, Yu D, Chen CS, He J, Gu D. A quick self-assessment tool to identify individuals at high risk of type 2 diabetes in the Chinese general population. J Epidemiol Community Health. 2010; 64:236-42

Vivek KS, Prabhakaran RD, Jeemon P, Ramakrishnan L, Shah P, Shah B et al. Development of a clinical risk score in predicting undiagnosed diabetes in urban Asian Indian adults: a population-based study. CVD Prevention and Control. 2008; 3:141

Noble D, Mathur R, Dent T, Meads C, Greenhalg T. Risk models and scores for type 2 diabetes: systematic review. BMJ. 2011; 343

Lee YH, Bang H, Kim HC, Kim HM, Park SW, Kim DJ. A Simple Screening Score for Diabetes for the Korean Population. Development, validation, and comparison with other scores. Diabetes Care. 2001; 35(8): 1723-30

Sharma KM, Rajani HR, Nguyen H, Shetty S, Datta M, Venkat KM. Indian Diabetes Risk Score Helps to Distinguish Type 2 from Non-Type 2 Diabetes Mellitus (GDRC-3). J Diabetes Sci Techno. 2011; 5(2):419-25

D’Souza MS, Amirtharaj A, Venkatesaperumal R, Isac C, Maroof S. Risk-assessment score for screening diabetes mellitus among Omani adults. SAGE Open Medicine. 2013; 1

Echouffo JB, Prorok P. Considerations in the design of randomized trials to screen for type 2 diabetes. Clin Trials. 2014; 11(3): 284-91

Canadian Task Force on Preventive Health Care. Recommendations on screening for type 2 diabetes in adults. CMAJ. 2012; 184(15): 1687-96

Lumb A. Diabetes and exercise. Clin Med. 2014; 14(6): 673-76

Dunkley A, Bodicoat DH, Greaves CJ, Russell C, Yates T, Davies MJ. Diabetes Prevention in the Real World: Effectiveness of Pragmatic Lifestyle Interventions for the Prevention of Type 2 Diabetes and of the Impact of Adherence to Guideline Recommendations a Systematic Review and Meta-analysis. Diabetes Care. 2014; 37(4): 922-33

Vermunt PAW, Milder EIJ, Wielaard F, Van Oers J,Westert GP. An active strategy to identify individuals eligible for type 2 diabetes prevention by lifestyle intervention in Dutch primary care: the APHRODITE study. Family Practice. 2010; 27(3): 312-19

Gerstein HC, Yusuf S, Bosch J, Pogue J, Sheridan P, Dinccag N, et al. DREAM (Diabetes Reduction Assessment with ramipril and rosiglitazone Medication) Trial Investigators. Effect of rosiglitazone on the frequency of diabetes in patients with impaired glucose tolerance or impaired fasting glucose: a randomized controlled trial. Lancet. 2006; 368: 1096-105

Herman WH, Brandle M, Zhang P, Williamson DF, Matulik MJ, Ratner RE, et al. Diabetes Prevention Program Research Group. Costs associated with the primary prevention of type 2 DM in the diabetes prevention program. Diabetes Care. 2003; 26: 36-47

Hippisley J, Coupland C, Robson J, Sheikh A, Brindle P. Predicting risk of type 2 diabetes in England and Wales: prospective derivation and validation of QD Score. BMJ; 2009

Rahman M, Simmons RK, Harding AH, Wareham NJ, Griffin SJ. A simple risk score identifies individuals at high risk of developing type 2 diabetes: a prospective cohort study. Fam Pract. 2008; 25:191-6

Wilson PW, Meigs JB, Sullivan L, Fox CS, Nathan DM, D’Agostino RB. Prediction of incident DM in middle-aged adults: the Framingham offspring study. Arch Intern Med. 2007; 167:1068-74

Lindström J, Tuomilehto J. The diabetes risk score: a practical tool to predict type 2 diabetes risk. Diabetes Care. 2003; 26:725-31

Naranjo AA, Rodríguez Y, Llera RE, Aroche R. Diabetes Risk in a Cuban Primary Care Setting in Persons with No Known Glucose Abnormalities. MEDICC Rev. 2013; 15(2):16-19

Enlaces refback

  • No hay ningún enlace refback.

Comentarios sobre este artículo

Ver todos los comentarios


Copyright (c) 2015